FDA Information
The FDA approved doxazosin in 1995.
On February 28th 2006, the FDA approved safety labeling revisions for doxazosin mesylate tablets (Cardura®, made by Pfizer Inc.) to warn of the risk for intraoperative floppy iris syndrome during cataract surgery in patients receiving or previously treated with this or other alpha-1 blockers.
Please visit the official site of the FDA for further information.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?
What storage conditions are needed for this medicine?
In case of an emergency/overdose